1,0
8 ago 2025
Dipendente anonimo
Ex dipendente
Boston, MA
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Nice product in terms of the cognitive screening tasks
Svantaggi
Weird C-suite. CEO is pretty much in laws with the investor which is why they got funding in the first place but haven’t raised series C. Teams don’t align. Company not doing well and product isn’t hitting the market and selling as they anticipated, and it hasn’t for years. Mostly sales people and very few with actual clinical experience in the company in general, yet they try to sell to clinicians